Allergan Applies for Patent on 2,5-Dioxoimidazolidin-1-Yl-3-Phenylurea Derivatives as Formyl Peptide...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1849882646

Allergan Applies for Patent on 2,5-Dioxoimidazolidin-1-Yl-3-Phenylurea Derivatives as Formyl Peptide Receptor Like-1 (FPRL-1) Receptor Modulators

Full title

Allergan Applies for Patent on 2,5-Dioxoimidazolidin-1-Yl-3-Phenylurea Derivatives as Formyl Peptide Receptor Like-1 (FPRL-1) Receptor Modulators

Publisher

New Delhi: Pedia Content Solutions Pvt. Ltd

Journal title

Global IP News. Pharmaceutical Patent News, 2016

Language

English

Formats

Publisher

New Delhi: Pedia Content Solutions Pvt. Ltd

Subjects and topics

Full title

Allergan Applies for Patent on 2,5-Dioxoimidazolidin-1-Yl-3-Phenylurea Derivatives as Formyl Peptide Receptor Like-1 (FPRL-1) Receptor Modulators

Record Identifier

TN_cdi_proquest_wirefeeds_1849882646

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1849882646

Log in as a Library member

Celebrating and sharing stories of Indigenous Australia, and helping to locate and prioritise Indigenous voices in the Library's collections.

Resources and programs for school and university students, teachers, families and lifelong learners.

Showcasing people, places and ideas inspired by the collection and the library community.